DIABETIC MEDICINE, cilt.33, ss.497-505, 2016 (SCI İndekslerine Giren Dergi)
AimTo evaluate the efficacy and safety of twice-daily insulin degludec/insulin aspart vs. twice-daily biphasic insulin aspart 30 in people with Type 2 diabetes mellitus who were naive to insulin.